Synagis
- Product NDC
- 60574-4113
- 11-digit product format
- 605744113
- Labeler code
- 60574
- Product ID
- 60574-4113_14cf114d-3f1e-485b-83f3-61d88c3c1a98
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- palivizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- MedImmune, LLC
- Application
- BLA103770
- Marketing category
- BLA
- Marketing start
- 1998-06-19
- Marketing end
- 0000-00-00
- Substance
- PALIVIZUMAB
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Antibodies, Monoclonal [CS],Fusion Protein Inhibitors [MoA],Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60574-4113-1 | 60574411301 | 1 mL in 1 VIAL, SINGLE-DOSE (60574-4113-1) | 1 ml | 2005-09-28 | 0000-00-00 | No | No | Current |